In addition, HSP treatment prevented HFD-induced body weight gain and hepatic steatosis in SD rats; HSP treatment attenuated HFD-induced ERS and inflammation in vivo and in vitro. The gene discussed is HSP90B2P; the disease is amelogenesis imperfecta type 1G.